Average Co-Inventor Count = 3.30
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Astrazeneca Ab (22 from 1,500 patents)
2. Cancer Research Technology Limited (4 from 263 patents)
26 patents:
1. 12410187 - Fused tricyclic compounds useful as anticancer agents
2. 11787786 - Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor 1
3. 11613539 - Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
4. 11352369 - Pyridine and pyrimidine derivatives
5. 11124501 - Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor I
6. 10882858 - Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
7. 10717746 - Chemical compounds
8. 10457679 - Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
9. 10189821 - Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor I
10. 10189834 - Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
11. 9856255 - Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
12. 9845331 - Chemical compounds
13. 9822111 - Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
14. 9701664 - Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor 1
15. 9428503 - Imidazo[4,5-c]quinolin-2-one compounds and their use in treating Cancer